These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 4471281

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Functional and clinical evaluation of feprazonebromhexine association in bronchopulmonary diseases.
    Del Bono N, Quartieri F, Renda B, Sconosciuto F, Vibelli C.
    Panminerva Med; 1978; 20(2):117-22. PubMed ID: 360150
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Asthma and chronic bronchitis. Can family physicians predict rates of progression?
    van Schayck CP, Dompeling E, Putters R, Molema J, van Weel C.
    Can Fam Physician; 1995 Nov; 41():1868-76. PubMed ID: 8563504
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Long-term treatment of severe chronic asthma and bronchitis with a long-acting corticosteroid.
    Deschepper P.
    Acta Tuberc Pneumol Belg; 1974 Nov; 65(2):243-8. PubMed ID: 4213596
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [1-second value and oscillatory airway resistance in the evaluation of the effectiveness of beta-adrenergic agents under general practice conditions].
    Kropp R, Aurich R.
    Prax Klin Pneumol; 1983 Nov; 37(11):1178-83. PubMed ID: 6361723
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Disodium cromoglycate in the treatment of bronchial asthma and asthma-like chronic bronchitis].
    Serembre M.
    Folia Allergol (Roma); 1971 Nov; 18(2):182-6. PubMed ID: 5111816
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.
    Tirimanna PR, Den Otter JJ, Van Schayck CP, Van Herwaarden CL, Folgering H, Van Weel C.
    Br J Gen Pract; 1996 Jan; 46(402):15-8. PubMed ID: 8745846
    [Abstract] [Full Text] [Related]

  • 38. [Role of intal in the reduction of corticosteroid doses in the treatment of bronchial asthma and chronic spastic bronchitis].
    Madalińska M, Droszcz W, Lech B, Garlicki A, Piotrowska B.
    Pneumonol Pol; 1981 Jan; 49(8-9):633-5. PubMed ID: 6795601
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Bronchial reactivity following corticoid treatment].
    M'Raihi ML, Djemel A, Ladjimi S, Zegaya M.
    Tunis Med; 1990 Apr; 68(4):271-4. PubMed ID: 2353367
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.